Pulse Biosciences (PLSE) Asset Utilization Ratio (2022 - 2025)

Pulse Biosciences' quarterly Asset Utilization Ratio came in at 0.0 in Q3 2025, up 687.07% quarter-over-quarter from 0.0 in Q3 2023.

Pulse Biosciences has reported Asset Utilization Ratio for 3 years, with the latest figure at 0.0 in Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio changed N/A year-over-year to 0.0; the trailing twelve-month figure through Sep 2025 stood at 0.0 (changed N/A YoY), and the FY2022 full-year result was 0.01, down 63.81% from the prior year.
  • Asset Utilization Ratio for Q3 2025 stood at 0.0, up from 0.0 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.05 in Q2 2022, with the low at 0.0 in Q3 2023.
  • Average Asset Utilization Ratio over 3 years is 0.01, with a median of 0.0 recorded in 2023.
  • Peak annual rise in Asset Utilization Ratio reached 100.23% in 2023, while the deepest fall reached 100.52% in 2023.
  • Tracing PLSE's Asset Utilization Ratio over 3 years: stood at 0.01 in 2022, then sank by 101.44% to 0.0 in 2023, then surged by 687.07% to 0.0 in 2025.
  • The last three Asset Utilization Ratio figures came in at 0.0 (Q3 2025), 0.0 (Q3 2023), and 0.0 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 0.52
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 0.40
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 0.64
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 0.77
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.58
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.33
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 0.65
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 0.54
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 0.75
10 Pulse Biosciences 1.72 Bn 1.72 Bn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 0.01
Sep 30, 2022 0.02
Jun 30, 2022 0.05